CASTLE BIOSCIENCES, INC. Amortization of Debt Issuance Costs and Discounts
CASTLE BIOSCIENCES, INC. (CSTL) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2022-02-28
- CASTLE BIOSCIENCES, INC. amortization of debt issuance costs and discounts for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. amortization of debt issuance costs and discounts for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. amortization of debt issuance costs and discounts for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. amortization of debt issuance costs and discounts for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. amortization of debt issuance costs and discounts for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- CASTLE BIOSCIENCES, INC. amortization of debt issuance costs and discounts for fiscal 2020 was $839.00K, a 56.42% decline from fiscal 2019.
- CASTLE BIOSCIENCES, INC. amortization of debt issuance costs and discounts for fiscal 2019 was $1.93M, a 240.11% increase from fiscal 2018.
- CASTLE BIOSCIENCES, INC. amortization of debt issuance costs and discounts for fiscal 2018 was $566.00K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 6 month as first filed | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 9 month as first filed | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $0.00 derived: sum of 2 quarters · filed 2021-11-08 | $0.00 10-Q · filed 2021-11-08 | $173.00K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | $173.00K derived: sum of 3 quarters · filed 2022-02-28 | $387.00K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | $173.00K derived: sum of 2 quarters · filed 2022-02-28 | $387.00K derived: sum of 3 quarters · filed 2022-02-28 | $615.00K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-12-31 | $173.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $387.00K derived: sum of 2 quarters · filed 2022-02-28 | $615.00K derived: sum of 3 quarters · filed 2022-02-28 | $839.00K 10-K · filed 2022-02-28 | ||
| 2020-09-30 | $214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $442.00K derived: sum of 2 quarters · filed 2021-11-08 | $666.00K 10-Q · filed 2021-11-08 | $900.00K derived: sum of 4 quarters · filed 2021-11-08 | ||
| 2020-06-30 | $228.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $452.00K 10-Q · filed 2021-08-09 | $686.00K derived: sum of 3 quarters · filed 2021-08-09 | $1.13M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $224.00K 10-Q · filed 2021-05-10 | $458.00K derived: sum of 2 quarters · filed 2021-05-10 | $899.00K derived: sum of 3 quarters · filed 2021-05-10 | $1.81M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $675.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.59M derived: sum of 3 quarters · filed 2021-03-11 | $1.93M 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $441.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.36M derived: sum of 2 quarters · filed 2020-11-09 | $1.69M 10-Q · filed 2020-11-09 | $1.69M 10-Q · filed 2019-11-12 | $1.83M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $916.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.25M 10-Q · filed 2020-08-10 | $1.25M 10-Q · filed 2019-09-03 | $1.39M derived: sum of 3 quarters · filed 2020-08-10 | $1.53M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $334.00K 10-Q · filed 2020-05-11 | $473.93K derived: sum of 2 quarters · filed 2020-05-11 | $613.20K derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $139.93K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $279.20K derived: sum of 2 quarters · filed 2020-03-10 | $566.00K 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $139.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $426.07K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $286.80K 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |